Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Journal of Immunology Research
|
October 28, 2017
Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells
Shiming Ye, Melvin I Fox, Nicole A Belmar, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
July 7, 2016
Evaluation of Anti-Inflammatory Potential of the New Ganghwaljetongyeum on Adjuvant-Induced Inflammatory Arthritis in Rats
Wangin Kim, Sangbin Park, Chanhun Choi, et al.
NPJ Digital Medicine
|
May 2, 2025
Small language models learn enhanced reasoning skills from medical textbooks
Hyunjae Kim, Hyeon Hwang, Jiwoo Lee, et al.
Journal of Cancer Research and Clinical Oncology
|
October 18, 2012
Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb
Debra T Chao, Mian Su, Sonia Tanlimco, et al.
Scientific Reports
|
May 19, 2026
Comparing clinical outcomes of rFSH versus rFSH+HP-hMG in women undergoing in vitro fertilization-embryo transfer in real‑world practice: a retrospective study
Myung Joo Kim, Jieun Ko, Donghee Choi, et al.
The Journal of Experimental Medicine
|
June 9, 2021
VISTA is an activating receptor in human monocytes
Bryan M Rogers, Laura Smith, Zoltan Dezso, et al.
Cancer Immunology Research
|
August 30, 2019
A Bispecific Molecule Targeting CD40 and Tumor Antigen Mesothelin Enhances Tumor-Specific Immunity
Shiming Ye, Diane Cohen, Nicole A Belmar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanisms
Patricia A Culp, Donghee Choi, Yongke Zhang, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Journal of Immunology Research
|
October 28, 2017
Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells
Shiming Ye, Melvin I Fox, Nicole A Belmar, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
July 7, 2016
Evaluation of Anti-Inflammatory Potential of the New Ganghwaljetongyeum on Adjuvant-Induced Inflammatory Arthritis in Rats
Wangin Kim, Sangbin Park, Chanhun Choi, et al.
NPJ Digital Medicine
|
May 2, 2025
Small language models learn enhanced reasoning skills from medical textbooks
Hyunjae Kim, Hyeon Hwang, Jiwoo Lee, et al.
Journal of Cancer Research and Clinical Oncology
|
October 18, 2012
Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb
Debra T Chao, Mian Su, Sonia Tanlimco, et al.
Scientific Reports
|
May 19, 2026
Comparing clinical outcomes of rFSH versus rFSH+HP-hMG in women undergoing in vitro fertilization-embryo transfer in real‑world practice: a retrospective study
Myung Joo Kim, Jieun Ko, Donghee Choi, et al.
The Journal of Experimental Medicine
|
June 9, 2021
VISTA is an activating receptor in human monocytes
Bryan M Rogers, Laura Smith, Zoltan Dezso, et al.
Cancer Immunology Research
|
August 30, 2019
A Bispecific Molecule Targeting CD40 and Tumor Antigen Mesothelin Enhances Tumor-Specific Immunity
Shiming Ye, Diane Cohen, Nicole A Belmar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanisms
Patricia A Culp, Donghee Choi, Yongke Zhang, et al.
Page
of 3